Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-03-16 Purchase | 2022-03-18 8:01 pm | Poseida Therapeutics Inc. | PSTX | Ingalls Kerry D. Chief Operating Officer | 3,000 | $3.98 | $11,940 | 55,000 (Direct) | View |
| 2021-11-17 Purchase | 2021-11-18 9:12 pm | Poseida Therapeutics Inc. | PSTX | Ingalls Kerry D. Chief Operating Officer | 2,000 | $7 | $14,000 | 2,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-03-01 Option Award | 2022-03-01 7:29 pm | N/A 2032-02-29 | Poseida Therapeutics Inc. | PSTX | Ingalls Kerry D. Chief Operating Officer | 122,568 | $0 | 124,568 (Direct) | View |
| 2021-02-04 Option Award | 2021-02-05 4:53 pm | N/A 2031-02-03 | Poseida Therapeutics Inc. | PSTX | Ingalls Kerry D. Chief Operating Officer | 137,000 | $0 | 137,000 (Direct) | View |
Ownership | 2020-07-09 6:00 pm | N/A 2029-10-16 | Poseida Therapeutics Inc. | PSTX | Ingalls Kerry D. Chief Operating Officer | 0 | $0 | 128,307 (Direct) | View |